Brevan Howard Capital Management »

Silverback Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Silverback Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.001477.353k477.3535k477.354k477.3545k477.355k32.92k32.9205k32.921k32.9215k32.922k
Value ($)Share countHistorical SPRY position of Brevan Howard Capital … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $477k 33k 14.50

More positions owned by Brevan Howard Capital Management

Select Sector Spdr Tr Financial (XLF)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Newmont Mining Corporation Call Option (NEM)
Select Sector Spdr Tr Technology Call Option (XLK)

View all positions for Brevan Howard Capital Management

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics